Novel Biomarkers in Cardiovascular Disease: From Bench to Bedside
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Endocrinology and Metabolism".
Deadline for manuscript submissions: closed (30 April 2021) | Viewed by 2891
Special Issue Editors
Interests: acute coronary syndrome; interventional procedures and pharmacological therapy; reperfusion injury; arginine metabolism; endothelial biology; metabolism and regeneration; microcirculation; cardiogenic shock and heart failure
Special Issues, Collections and Topics in MDPI journals
Interests: biomarkers; myocardial ischemia; heart failure; HFpEF; microRNA; vascular/endothelial stress; atherosclerosis; valvular heart disease; risk assessment; mortality prediction
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Biomarker diagnostics in diseases as myocardial infarction, heart failure, chronic kidney disease, and inflammatory conditions have proven to be of substantial help in the last couple of years. Biomarkers such as troponins (myocardial ischemia) and NT-proBNP (myocardial wall stress), interleukin-6 or procalcitonin in inflammatory diseases have shown great potential, though, they just cover aspects of the pathophysiological process. Research on novel biomarkers is important for a better understanding of multiple cellular pathways that are involved in these disease conditions. For example, when heart disease is accompanied by other pathophysiological entities such as arrhythmia, renal failure, diabetes, pulmonary hypertension, or COPD, risk assessment could become even more complicated. Further research on biomarkers could help identify those patients at higher risk, plan individualized treatments, and improve secondary prevention strategies.
This Special Issue is dedicated to all original research articles and reviews, exploring novel biomarkers in cardiovascular diseases, focus on therapeutic targets, pathological effects and signaling pathways. Purely clinical investigations are not suitable but clinical submissions with some component of deep molecular studies are quite welcome.
Prof. Dr. Christian Jung
Dr. Michael Lichtenauer
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- troponins
- NT-proBNP
- interleukin-6
- procalcitonin
- heart failure
